CD8A and neoplasm: Overall, neither a high frequency of OVA-specific CD8+ T cells nor a high proportion of TCM cells could solely confer prolonged tumor protection, reinforcing the idea that both quantity and quality are important in achieving long-term prophylactic immunity.